4//SEC Filing
Stengone Carmine N. 4
Accession 0001372514-24-000115
CIK 0001372514other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 6:32 AM ET
Size
5.2 KB
Accession
0001372514-24-000115
Insider Transaction Report
Form 4
Stengone Carmine N.
Director
Transactions
- Purchase
Common Stock
2024-09-11$3.68/sh+1,250$4,600→ 1,250 total
Footnotes (1)
- [F1]The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. The reported price of $3.68 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001861519
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 6:32 AM ET
- Size
- 5.2 KB